Prednisolone sodium metazoate

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePrednisolone sodium metazoate
Drug Alias NamePrednisolona sodium metazoatePrednisolonum sodium metazoateATL-2502TSD-0011COLAL-PRED
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsRejection of renal transplantationLupus NephritisMultiple Sclerosis +[14
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[24
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesAlizyme
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantationLupus NephritisMultiple Sclerosis +[14

Other Information

ATC CodeN/A